EMR POLYMERS LIMITED

Company number 06455767 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: EMR POLYMERS LIMITED

Financial Health Score: A (Provisional)

Explanation: This score is based on the company’s strong compliance record, significant capital base, and active, well-structured governance. However, it is provisional because no detailed financial statements (turnover, profit, assets/liabilities) are available in the provided data. A full diagnosis would require actual balance sheet and profit & loss figures.


Key Vital Signs (Based on Available Data)

Vital Sign Finding Interpretation
Compliance Health Accounts and confirmation statement up to date; no overdue filings. ✅ Normal – no warning signs of administrative distress.
Capital Structure Share capital £13,743,988.34 – very high for a private company. ✅ Strong – suggests significant shareholder investment or retained equity.
Ownership Stability Single corporate PSC (Invenens Limited) owning >75% of shares. ⚠️ Controlled – typical of a wholly-owned subsidiary; may be reliant on parent for strategic/financial support.
Activity Status Active, with current directors and secretary. ✅ Alive – no signs of dormancy, dissolution, or insolvency proceedings.
Recent Name Change Changed from MBA POLYMERS UNITED KINGDOM LIMITED on 18 June 2026. 🔄 Recent rebrand – could indicate restructuring, new ownership, or strategic pivot.
Industry Sector Manufacture of plastic products (22290) and recycling of sorted materials (38320). ✅ Sector resilience – demand for recycled plastics is growing, but subject to raw material price volatility and regulatory changes.

Missing Vital Signs (Critical Gaps)

  • Turnover / Revenue – no indication of income level or growth.
  • Profitability – no P&L data to assess margins or retained earnings.
  • Liquidity – no current assets or liabilities to calculate working capital.
  • Net Assets – cannot compute equity cushion or gearing.
  • Cash Flow – no cash or debt information.

Diagnosis: Inconclusive but Favourable Outlook

Primary Condition: The company shows no crisis symptoms – no overdue filings, no insolvency flags, active directors, and a substantial capital base. This is like a patient with a strong heartbeat, clear lungs, and good blood pressure, but whose blood work and internal scans are not yet available. The underlying structure suggests a well-capitalised, compliant entity likely operating as a subsidiary of Invenens Limited.

Potential Hidden Issues: - Dependency risk – 100% control by a single corporate owner may limit strategic flexibility. - Name change recency – could mask a past operational change, merger, or even a distressed rebrand. Without historical financial data, we cannot rule out prior financial strain. - Subsidiary transparency – group support can mask weak standalone solvency.


Recommendations (Based on Available Data)

  1. Obtain Full Financial Statements – Request the latest filed annual accounts (available from Companies House) to assess liquidity, profitability, and net asset strength. Without these, any assessment is incomplete.

  2. Monitor the PSC Relationship – If the parent company (Invenens Limited) shows signs of financial weakness, the subsidiary could be at risk. Check the parent’s own filings.

  3. Review the Name Change Rationale – Investigate why MBA POLYMERS UNITED KINGDOM LIMITED changed name. Confirm it was a simple rebrand and not a result of reputational damage, legal action, or restructuring to hide past underperformance.

  4. Stress-Test Liquidity – Even with high share capital, if the company has large current liabilities or poor cash conversion, working capital could be tight. Ask management for aged debtor/creditor reports.

  5. Check Industry Benchmarks – Compare turnover per employee (if staff numbers become available) and gross margins against SIC 22290 and 38320 averages to gauge competitive health.


Perspective: Financial Health Diagnostician · Model: deepseek/deepseek-v4-flash · Generated 28 September 2026